Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up

Bibliographic Details
Title: Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up
Authors: Milosevic, E., Dujmovic, I., Markovic, M., Mesaros, S., Rakocevic, G., Drulovic, J., Stojkovic, M. M., Popadic, D.
Source: JOURNAL OF NEUROIMMUNOLOGY. 287:64-70
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN372404011&indx=1&recIds=ETOCRN372404011
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:01655728
Published in:JOURNAL OF NEUROIMMUNOLOGY
Language:English